Soaring long term sick numbers fuelling GIP demand but product pricing ‘all over the place’ – analysis

The business case for group income protection (GIP)  has perhaps never been more relevant. The aftershocks of the pandemic are still being felt with the numbers of long term sick at 26 times the levels they were in the period before Covid. Consequently, UK plc has been faced with a productivity problem meaning companies of